ВВЕДЕНИЕ 16 страница

Tanaka I., Koike K. (Eds.) Japanese Coloring 1982 // Therapie (Libro Port Co. Tokyo), 1996. V. 51. No. 6. P. 667-676.

Tangrea J. A. Patient participation and compliance in cancer chemopre-vention trials: issues and concerns // Proc. Soc. Exp. Biol. Med. 1997. V. 216. No. 2. P. 260-265.

Terman M., Terman J. S., Quitkin E. M. et al. Light therapy for seasonal affective disorder // Neuropsychopharmacol. 1989. V. 2. P. 1-21.

Thoma H., Kachele H. Psychoanalytic Practice. 2. Clinical Studies. Berlin; Heidelberg: Springer, 1992. 540 s.

Thor-Wiedermann S., Wiedermann G. Placebos? Uber die reproduzierbar nachweisbaren Wirkungen von Placebo // Deutsch. Med. Wschr. 1988. Bd. 113. S. 871-873.

Totman R. Cognitive dissonance in the placebo treatment of insomnia — a pilot experiment // Brit. J. of Med. Psychology. 1976. V. 49. No. 4. P. 393-400.

Tsuang M. 2\. Boor M., Fleming J. A. Psychiatric aspects of traffic accidents // Amer. J. Psychiatry. 1985. V. 142. P. 538-546.

Turner J. A. et al. The importance of placebo effects in pain treatment and research // JAMA. 1994. V. 271. No. 20. P. 1609-1614.

Tye L. Doctors' orders often disobeyed. Elderly found to neglect prescriptions // The Boston Globe. 1998,

May 13. P. A12.

Van der Meer F. J. M. et al. The role of compliance as a cause of instability in oral anticoagulant therapy // Brit. J. Haematology. 1997. V. 98. No. 4. P. 893-900.

Vinar O. Dependence on a placebo. A case report // Brit. J. Psychiatr. 1969. V. 115. P. 1189.

Vogel A. V., Goodwin J. S., Goodwin J. M. The therapeutics of placebo // Amer. Family Physician. 1980. V. 22. No. 1. P. 105-109.

Плацебо и терапия

Wall M., Wheeler S. Benefits of the placebo effect in the therapeutic relationship // Complementary Therapeutics in Nursing and Midwifery 1996. V. 2. No. 6. P. 160-163.

Wardrope J. Bed shortage — hospitals need support for coping with emergency work // Brit. Med. J.

1997. V. 314. No. 7077. P. 369.

Weissman M. M. et al. The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes // Amer. J. Psychiatry. 1979. V. 136. P. 555-558.

White L., Tursky B., Schwartz G. E. (Eds.) Placebo: Theory, research and mechanisms. N. Y.: Guilford Press, 1985.

What price psychotherapy? // Brit. Med. J. 1984. V. 288. No. 6420. P. 809-810.

Wickramasera I. A conditioned response model of the placebo effect: predictions from the model // Biofeedback and Self-Regulation. 1980. V. 5. P. 5-18.

Wilcox С S. et al. Predictors of placebo response: a retrospective analysis // Psychopharmacol. Bull.

1992. V. 28. No. 2. P. 157.

Wilkins W. Psychotherapy: the powerful placebo // J. of Consulting and Clinical Psychology. 1984. V. 52. P. 570-573.

Willemsen-Swlnkels S. H. N. et al. Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. — Double-blind placebo-controlled studies // Arch. Gen. Psychiatry. 1995 V. 52. No. 9. P. 766-773.

Wolf S. The pharmacology of placebos // Pharmacol. Revs. 1959. V. 11. P. 689-704.

Working-Group. Minimum information for sensible use of self-prescribed medicines // Lancet. 1977. Nov. 12. P. 1017-1019.

Young M. A., Fogg L. F. Predicting response to treatment: Differentiating active-factor and non-specific effects // Statistics in Medicine. 1990. V. 9. P. 253-261.

Zajiceh G. A scientific framework for the placebo effect // Cancer J. 1997. V. 10. P. 236-237.

Zitrin C. M., Klein D. F., Woerner M. G. Treatment of agoraphobia with group exposure in vivo and imipramine // Archives Gen. Psychiatry. 1980. V. 37. P. 63-72.